Home › Type 2 Diabetes › Mississippi › Jackson
Type 2 Diabetes clinical trials in Jackson, MS
5 studies for Type 2 Diabetes are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
RecruitingPhase 3
- SKY Clinical Research Network Group - Ridgeland, Ridgeland · 9 mi away
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Jackson
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
RecruitingPhase 2
- Sky Integrative Medical Center, Ridgeland · 9 mi away
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Ridgeland · 9 mi away
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RecruitingPhase 3
- University of Mississippi Medical Center, Jackson
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Miami, FL19 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in Jackson
- Obesity8 studies
- Overweight6 studies
- Steatotic Liver Disease5 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer5 studies
- Prostate Cancer5 studies
- Breast Cancer5 studies
- Sickle Cell Disease5 studies
- Heart Failure5 studies
- Burkitt Lymphoma4 studies
- Acute Myeloid Leukemia4 studies
- Attention Deficit Hyperactivity Disorder4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.